Literature DB >> 1854876

Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis.

W K Lo1, K T Chan, A C Leung, S W Pang, C Y Tse.   

Abstract

Sclerosing peritonitis (SP) is an uncommon but serious complication of CAPD with various suggested etiologies. We have documented 14 cases of SP in 18 patients who had used chlorhexidine in alcohol (ChA) in the connection procedure for CAPD. Thirteen died. Nine of the 14 patients had been transferred to hemodialysis or renal transplantation, yet all still developed symptoms of SP within a few months after transfer - even the 5 who were originally asymptomatic. The main symptoms of SP were peritoneal ultrafiltration failure, exudative bloody ascites and intestinal obstruction. They presented at around 5 years (30-80 months) after commencement of CAPD. Most deaths were related to intestinal obstruction. Four other patients with a comparable duration of ChA exposure were continued on CAPD with the Travenol Spike System (TSS), without further exposure to ChA. They were all asymptomatic of SP after 9-12 months. Comparing the 2 groups of asymptomatic patients, those transferred to TSS had a much better outcome after 9 months than those transferred to HD or renal transplantation (P = 0.0476). We suggest that ChA is the main cause of SP in our patients and that continuing CAPD without further exposure to ChA is a better alternative than stopping CAPD to prevent the progression of SP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854876

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  6 in total

1.  Iatrogenic iodine as a cause of hypothyroidism in infants with end-stage renal failure.

Authors:  Richard Brough; Caroline Jones
Journal:  Pediatr Nephrol       Date:  2005-12-30       Impact factor: 3.714

2.  Burkholderia cepacia Exit-Site Infection in Peritoneal Dialysis Patients-Clinical Characteristics and Treatment Outcomes.

Authors:  Desmond Y H Yap; Jasper F W Chan; Terence Yip; Maggie M Y Mok; Lorraine P Y Kwan; Wai Kei Lo; Tak Mao Chan
Journal:  Perit Dial Int       Date:  2015-10-22       Impact factor: 1.756

3.  Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.

Authors:  Sudabeh Alatab; Iraj Najafi; Gholamreza Pourmand; Mostafa Hosseini; Soroosh Shekarchian
Journal:  Ren Fail       Date:  2016-10-24       Impact factor: 2.606

4.  Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Authors:  Jesús Loureiro; Guadalupe Gónzalez-Mateo; José Jimenez-Heffernan; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera Peralta
Journal:  Int J Nephrol       Date:  2013-02-10

5.  Rare extraperitoneal involvement with fatal outcome in a case of bilateral luteinized thecoma of the ovaries with sclerosing peritonitis.

Authors:  Mohamed A Medhat; Mohamed A Y Abdel Malek; Saad Zaki; Ahmed Helmy; James J Driscoll
Journal:  Case Rep Oncol Med       Date:  2014-06-05

Review 6.  Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.

Authors:  Rajesh M Jagirdar; Andreas Bozikas; Sotirios G Zarogiannis; Maria Bartosova; Claus Peter Schmitt; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-11-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.